IBD
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Tasty and healthy diet reduces fecal calprotectin in HIGH-RISK first-degree relatives of patients with crohn's disease: pionir randomized crossover trial.
Clinical takeawayConsider recommending the Tasty&Healthy diet to high-risk first-degree relatives of Crohn's disease patients with persistently elevated fecal calprotectin (>70μg/g) but no diagnostic endoscopic evidence of Crohn's disease, as it reduced median fecal calprotectin to 64μg/g compared to 112μg/g on habitual diet (P=0.022) and achieved ≥50% FC reduction in 71% vs 27% (RR=2.68, P=0.016). 79% rated T&H acceptable and 83% had good or complete adherence.
What it foundThe Tasty&Healthy diet reduced median fecal calprotectin to 64μg/g vs 112μg/g on habitual diet (P=0.022) and achieved ≥50% FC reduction in 71% vs 27% (RR=2.68, P=0.016).
ContextThis study provides early evidence that dietary intervention can modify low-grade intestinal inflammation in high-risk first-degree relatives of Crohn's disease patients with persistently elevated fecal calprotectin (>70μg/g) but no diagnostic endoscopic evidence of Crohn's disease, supporting ongoing prevention trials.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Turner D … Croitoru K · Gastroenterology · IF 25.1 · PubMed ↗